Figure 3.
Figure 3. Survival probabilities among patients in the following genetic categories: 17p- (17p deletion irrespective of VH mutation status), 11q- (11q deletion irrespective of VH mutation status), unmutated VH (homology ≥ 98% and no 17p or 11q deletion), and mutated VH (homology < 98% and no 17p or 11q deletion).7. / A) Among all 300 patients estimated median survival times were: 17p- 30 months, 11q- 70 months, VH ≥ 98% 89 months. and VH < 98% not reached (54% survival at 152 months)B) In Binet A patients only (n = 189) estimated median survival times were: 17p- 36 months, 11q- 68 months, VH ≥ 98% 86 months months, and VH < 98% not reached (52% survival at 152 months).

Survival probabilities among patients in the following genetic categories: 17p- (17p deletion irrespective of VH mutation status), 11q- (11q deletion irrespective of VH mutation status), unmutated VH (homology ≥ 98% and no 17p or 11q deletion), and mutated VH (homology < 98% and no 17p or 11q deletion).7 

A) Among all 300 patients estimated median survival times were: 17p- 30 months, 11q- 70 months, VH ≥ 98% 89 months. and VH < 98% not reached (54% survival at 152 months)B) In Binet A patients only (n = 189) estimated median survival times were: 17p- 36 months, 11q- 68 months, VH ≥ 98% 86 months months, and VH < 98% not reached (52% survival at 152 months).

Close Modal

or Create an Account

Close Modal
Close Modal